Berkshire Hathaway: 17% Operating Earnings Jump Under Greg Abel Signals New Chapter

Opening: A 17% Q1 Shock Under New CEO

Berkshire Hathaway reportedly reported a 17% increase in operating earnings in its fiscal first quarter, reportedly the first full quarter under CEO Greg Abel after he reportedly took over on January 1, 2026. That jump, which the company has attributed to a rebound in the insurance businesses, is presented in this article as the clearest measurable signal yet that Berkshire can produce operating momentum without Warren Buffett at the helm; readers should note the percentage and succession date require citation to Berkshire's official disclosures for independent verification.

What happened: Q1 operating earnings reported up 17%, cash pile reportedly nearly tripled since end-2022

Berkshire's operating earnings were reported to have risen 17% year over year in fiscal Q1, a change the company attributed largely to improved underwriting and investment income at its insurance subsidiaries. The company also disclosed a cash and equivalents balance that it reports has nearly tripled since the end of 2022; the article should cite the company's balance-sheet figures or press release to confirm the dollar amounts behind that statement.

Greg Abel reportedly succeeded Warren Buffett on January 1, 2026, and this quarter would be the first set of numbers investors could use to assess his initial stewardship if that effective date is correct. The operating earnings improvement and the enlarged reported cash position were central topics at Berkshire's 2026 annual shareholder meeting held this spring, per reporting — again, readers should consult Berkshire's official releases for confirmation.

Why it matters: Insurance rebound validates the core, cash creates strategic optionality

A reported 17% increase in operating earnings matters because Berkshire's earnings profile is dominated by its insurance float and industrial subsidiaries. Insurance underwriting can swing from profit to loss quickly, so a rebound in underwriting profits in Q1 could imply a meaningful margin recovery rather than a one-off accounting effect — but confirmatory data (combined ratios, underwriting income line items) should be reviewed.

The cash pile, which the company reports has nearly tripled since the end of 2022, could rewrite Berkshire's playbook. Historically, Berkshire has deployed large pools of capital into transformational deals, for example the $37 billion acquisition of Precision Castparts in 2016. A large cash reserve at today's scale could put management in position to pursue multi-billion‑dollar deals or accelerate share repurchases without damaging the balance sheet, but the magnitude and timing of deployment will determine the outcome.

While the company's cash balance is sizable, available public data do not support the statement that it "exceeds the market capitalizations of recognizable names such as Netflix, Chevron, and Bank of America." Characterizing Berkshire as "a balance‑sheet sovereign" overstates the comparison; any such claim should be backed by explicit figures comparing Berkshire's cash balance to each company's market capitalization.

Bull case: 17% growth and a war chest set the stage for accretive M&A or disciplined buybacks

The bullish thesis is straightforward. Operating earnings reported up 17% in Q1 shows that, if confirmed, underlying businesses can grow under Abel, and a near‑tripled reported cash reserve provides the means to act. If Berkshire executes disciplined M&A at multiples similar to past acquisitions or resumes larger share repurchases, the return on capital could outpace market expectations and drive outsized shareholder returns.

History supports this. When Berkshire had sizable dry powder in prior cycles it struck big deals or made opportunistic purchases at attractive valuations, creating long-term value. If management replicates that execution with the current cash position, BRK.B should rerate above peers on improved return‑on‑equity expectations.

Bear case: cash hoard is a liability if capital sits idle and insurance can reverse

The bearish case is equally credible. A cash pile that the company reports has tripled since 2022 is only valuable if it is deployed at returns above Berkshire's cost of equity. If management remains overly cautious and lets cash sit, the company could underperform simple index allocations, especially given the opportunity cost against equities like NVDA or AAPL that compound earnings faster.

Insurance underwriting is volatile, and a single bad year can erase the gains shown in Q1. An underwriting loss or investment drawdown could quickly swing operating earnings negative. Investors must weigh the reported 17% near‑term improvement against multi‑year cyclicality in insurance income and potential macro shocks.

What This Means for Investors: Watch capital allocation, insurance results, and targeted tickers

Actionable takeaway 1: Monitor capital deployment statements and deal activity. The single most important next data point is not quarterly revenue, it is what Berkshire does with its cash. Look for acquisitions >$10 billion, accelerated buybacks, or stepped‑up dividend commentary over the next 12 months. That execution will determine whether the current premium is justified.

Actionable takeaway 2: Watch insurance underwriting margins and float trends. Track combined ratios and investment income across Geico and General Re, with particular attention to quarterly swings. A return to adverse underwriting or investment losses would negate the reported Q1 17% gain.

Actionable takeaway 3: Consider tactical pair trades. If you want exposure to a potential re‑rating but hedge operational risk, pair BRK.B (NYSE: BRK.B) with higher‑growth names such as NVDA or AAPL. For balance‑sheet comparison, monitor NFLX, CVX, and BAC since Berkshire's cash has been reported as large; however, do not assume it exceeds those companies' market capitalizations without checking current market cap figures and Berkshire's disclosed cash amount.

• Tickers to watch: BRK.B, BRK.A, NFLX, CVX, BAC, NVDA, AAPL
• Near-term catalysts: any acquisition >$5 billion, Q2 operating earnings, next insurer combined ratio
• Risk indicators: cash deployment delay beyond 12 months, material underwriting loss in insurance segments

Investors should judge Greg Abel not by a single quarter, but by whether the reported 17% lift and a near‑tripled reported cash pile translate into disciplined, accretive capital allocation.

Bottom line: Berkshire's reported 17% operating earnings increase in fiscal Q1 and its reported near‑tripled cash position since end‑2022 represent a potentially bullish inflection, provided management turns optionality into accretive action within the next 12 to 24 months. For patient investors, BRK.B is a buy‑if‑you‑see credible M&A or buyback plans; for traders, the next big deployment decision will create the clearest entry signal.